iso4217:GBP
xbrli:pure
xbrli:shares
iso4217:GBP
xbrli:shares
SC760619
2024-04-01
2024-09-30
SC760619
2024-09-30
SC760619
2025-06-25
SC760619
2025-06-25
2025-06-25
SC760619
bus:Director2
2024-04-01
2024-09-30
SC760619
bus:Director1
2024-04-01
2024-09-30
SC760619
bus:SmallEntities
2024-04-01
2024-09-30
SC760619
bus:AuditExempt-NoAccountantsReport
2024-04-01
2024-09-30
SC760619
bus:FilletedAccounts
2024-04-01
2024-09-30
SC760619
bus:Director1
2024-04-01
2024-09-30
SC760619
2024-04-01
2024-09-30
SC760619
bus:PrivateLimitedCompanyLtd
2024-04-01
2024-09-30
Registration Number SC760619 (Scotland)
Filleted Unaudited Financial Statements
for the period 01 April 2024 to 30 September 2024
Financial Statements for the 6 month period ended 30 September 2024
NATURE OF BUSINESS AND PRINCIPAL ACTIVITIES
The company's principal activity during the year was that of a holding company
BOARD OF DIRECTORS
G Birrell
REGISTERED OFFICE
16 Alva Street
Financial Statements for the 6 month period ended 30 September 2024
STATEMENT OF FINANCIAL POSITION
Investments
2
813,995
813,995
Cash at bank and in hand
22,365
22,642
Creditors: amounts falling due within one year
3
73,157
225,407
Net current liabilities
(50,792)
(202,765)
Total assets less current liabilities
763,203
611,230
Creditors: amounts falling due after more than one year
4
(54,908)
(54,908)
Net assets
708,295
556,322
Called up share capital
5
3,336
3,336
Share premium account
5
300,626
300,626
Profit and loss account
404,333
252,360
Shareholders' funds
708,295
556,322
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. These financial statements and reports have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the statement of comprehensive income has been taken.
For the 6 month period ended 30 September 2024, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the 6 month period ended 30 September 2024 in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirments of the Companies Act 2006 with respect ot accounting records and the preparation of accounts.
The financial statements were approved and authorised for issue by the Board of Directors on 23 June 2025.
Signed on behalf of the Board of Directors
_______________________
_______________________
Financial Statements for the 6 month period ended 30 September 2024
STATEMENT OF FINANCIAL POSITION
The notes on pages 4 to 6 form part of these accounts.
Company registration number: SC760619
Financial Statements for the 6 month period ended 30 September 2024
NOTES TO THE FINANCIAL STATEMENTS
1.
Summary of significant accounting policies
1.1
General information and basis of preparation
Mardon Wealth Ltd is a private company limited by shares, registered in Scotland. The address of the registered office and registration number is given in the company information on page 1 of these financial statements.
These financial statements have been prepared in accordance with FRS 102 the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland as adapted by Section 1A of FRS 102 and the Companies Act 2006.
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling (£) which is the functional currency of the company and rounded to the nearest £.
The financial statements are prepared on a going concern basis and comply with the financial reporting standards of FRC including FRS102, "The Financial Reporting Standards applicable in the UK and Ireland" as adapted by Section 1A.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
Investments in joint ventures / associates are measured at cost less impairment.
Financial Statements for the 6 month period ended 30 September 2024
NOTES TO THE FINANCIAL STATEMENTS
1.3
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Financial Statements for the 6 month period ended 30 September 2024
NOTES TO THE FINANCIAL STATEMENTS
Shares in group undertakings
£
At 30 September 2024
813,995
At 30 September 2024
813,995
3.
Creditors: amounts falling due within one year
Creditors: amounts falling due within one year comprise:
Other creditors
59,258
211,508
Amounts owed to group undertakings
13,899
13,899
4.
Creditors: amounts falling due after more than one year
Other creditors
54,908
54,908
5.
Called up share capital
Authorised
2024
Number
2024
Number
Ordinary shares of £1 each
3,336
3,336
Alloted, called up and fully paid
2024
£
2024
£
Ordinary shares of £1 each
3,336
3,336
6.
Related party transactions
The company has taken advantage of exemption under FRS 102 Section 1A from the requirement to disclose related party transactions with wholly owned group undertakings.
Appendix - Additional XBRL Tags and Values
Accounting standards applied
Accounts status, audited or unaudited
Average number of employees during the period
Average number of employees during the period
Date of authorisation of financial statements for issue
Director signing Directors' Report
Director signing financial statements
End date for period covered by report
Entity current legal or registered name
Entity is dormant [true/false]
Name of individual auditor
Name of production software
Start date for period covered by report
UK Companies House registered number